Abstract:Abstract Introduction Signaling downstream of Ras is mediated by three major pathways, Raf/ERK, phosphatidylinositol 3 kinase (PI3K), and Ral guanine nucleotide exchange factor (RalGEF). Ras signal transduction pathways play an important role in breast cancer progression, as evidenced by the frequent over-expression of the Ras-activating epidermal growth factor receptors EGFR and ErbB2. Here we investigated which signal transduction pathways downstream of Ras contribute to EGFR-dependent transformation of telomerase-immortalized mammary epithelial cells HME16C. Furthermore, we examined whether a highly transcriptionally regulated ERK pathway target, PHLDA1 (TDAG51), suggested to be a tumor suppressor in breast cancer and melanoma, might modulate the transformation process. Methods Cellular transformation of human mammary epithelial cells by downstream Ras signal transduction pathways was examined using anchorage-independent growth assays in the presence and absence of EGFR inhibition. TDAG51 protein expression was down-regulated by interfering small hairpin RNA (shRNA), and the effects on cell proliferation and death were examined in Ras pathway-transformed breast epithelial cells. Results Activation of both the ERK and PI3K signaling pathways was sufficient to induce cellular transformation, which was accompanied by up-regulation of EGFR ligands, suggesting autocrine EGFR stimulation during the transformation process. Only activation of the ERK pathway was sufficient to transform cells in the presence of EGFR inhibition and was sufficient for tumorigenesis in xenografts. Up-regulation of the PHLDA1 gene product, TDAG51, was found to correlate with persistent ERK activation and anchorage-independent growth in the absence or presence of EGFR inhibition. Knockdown of this putative breast cancer tumor-suppressor gene resulted in increased ERK pathway activation and enhanced matrix-detached cellular proliferation of Ras/Raf transformed cells. Conclusion Our results suggest that multiple Ras signal transduction pathways contribute to mammary epithelial cell transformation, but that the ERK signaling pathway may be a crucial component downstream of EGFR activation during tumorigenesis. Furthermore, persistent activation of ERK signaling up-regulates TDAG51. This event serves as a negative regulator of both Erk activation as well as matrix-detached cellular proliferation and suggests that TDAG51 opposes ERK-mediated transformation in breast epithelial cells.

Inhibition of the Ras-ERK Pathway in Mitotic COS7 Cells is Due to the Inability of EGFR/Raf to Transduce EGF Signaling to Downstream Proteins.

Investigation of MEK Activity in COS7 Cells Entering Mitosis

The EGF Receptor is Activated During Mitosis and Its Cell Signaling is Mediated Differently Than in Interphase (802.13)

ERK Activity in Cellular Interphase and Mitosis

Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

C-Src Regulates Cell Cycle Proteins Expression Through Protein Kinase B/glycogen Synthase Kinase 3 Beta and Extracellular Signal-Regulated Kinases 1/2 Pathways in MCF-7 Cells

C-Src is Activated by the EGF Receptor in a Pathway that Mediates JNK and ERK Activation by Gonadotropin-Releasing Hormone in COS7 Cells

EGF stimulates the activation of EGF receptors and the selective activation of major signaling pathways during mitosis.

Simulation of Crosstalk Between Small GTPase RhoA and EGFR-ERK Signaling Pathway Via MEKK1

c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1/2 pathways in MCF-7 cells.

TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation

MEK Inhibitor, PD98059, Promotes Breast Cancer Cell Migration by Inducing Β-Catenin Nuclear Accumulation.

Type II Cgmp-Dependent Protein Kinase Inhibits EGF-induced MAPK/JNK Signal Transduction in Breast Cancer Cells

Regulation Of Egf-Stimulated Egf Receptor Endocytosis During M Phase

PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells

Altered MAP Kinase (ERK1,2) Regulation in Primary Cultures of Mammary Tumor Cells: Elevated Basal Activity and Sustained Response to EGF.

The Activation of ERK3 Signaling Pathway Blocks Cell Proliferation

Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2

Investigation of the Effect of Nocodazole on the PI3K/Akt Signaling Pathway in COS7 Cells.

Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells